DOI:
10.1039/C5RA02918J
(Communication)
RSC Adv., 2015,
5, 26491-26495
Efficient strategy for construction of 6-carbamoylfulvene-6-carboxylate skeletons via [3 + 2] cycloaddition of 1-cyanocyclopropane 1-ester with β-nitrostyrenes†
Received
15th February 2015
, Accepted 10th March 2015
First published on 16th March 2015
Abstract
An efficient and straightforward synthetic protocol has been developed for the preparation of 6-carbamoylfulvene-6-carboxylates via a cycloaddition reaction between 1-cyanocyclopropane 1-esters and β-nitrostyrenes for the generation of a wide range of structurally interesting and pharmacologically significant compounds. The reaction utilises Et3N promoted C–C bond cleavage, two new C–C bond formations of 1-cyanocyclopropane 1-ester with β-nitrostyrene and simultaneous conversion of a cyano group into amide in a domino fashion.
Fulvenes, which exhibit intriguing cross-conjugated molecular structures, are important classes of organic compounds that are not only widely used as synthetic building blocks and various kinds of functional materials,1 but they also have been recognized as privileged scaffolds, which can be found in many natural products and pharmaceuticals.2 Additionally, due to their abnormal electronic, spectroscopic and chemical properties, fulvenes and their derivatives also have attracted much attention from chemists studying theoretical chemistry.3 Fulvenes are generally synthesized via the condensation of aldehydes or ketones with cyclopentadiene in the presence of inorganic bases or alkoxides.4 Recently an improved protocol involved secondary amine-promoted condensation.5 In addition to the conventional base-promoted fulvene synthesis, coupling reactions of alkynes catalyzed by transition metals was another prominent reaction, such as Pd-catalyzed trimerization of alkynes,6 Pd catalyzed cross-coupling reactions of alkynes with vinyl halides,7 and with enone or enal moieties,8 Ti-catalyzed trimerization of tert-butylacetylene,9 silver-catalyzed Nazarov-type cyclization of R-hydroxyallenes,10 gold-catalyzed intramolecular furan/yne cyclization reaction.11 Additionally, fulvenes were easily accessible through organocatalytic domino reaction of electron-deficient 2,4-dienes with 2-halo-1,3-dicarbonyl compounds or heated cyclization of enediynes in the presence of the stable radical TEMPO (tetramethyl piperidyl oxide),12 Wolff rearrangement of ketenes,13 trifluoromethylation and cyclization of divinyl ketones,14 or [3 + 2] annulations of ethyl α-chlorocyclopropaneformates with acetyl acetone.15 However, these protocols could provide only a limited variety of fulvenes. To address this problem, further development of new and alternative synthetic strategies for functionalized fulvenes is highly desirable.
In recent years, the diverse and often unexpected reactivity of cyclopropanes and their derivatives have drawn considerable attention due to the simplicity of their synthesis and potential for variation of the aryl groups. Cyclopropanes and their derivatives easily undergo a variety of ring-opening reactions under the influence of a variety of conditions. Based on these special reactivity patterns, cyclopropanes and their derivatives have been recognized to be powerful building blocks in organic syntheses.16 Recently we reported the direct annulation of pyridine derivatives with 1-cyanocyclopropane 1-ester to form indolizine derivatives in a regioselective manner,17 which stimulated research into new pathways for the construction of cyclic units via the ring-opening reactions of activated donor–acceptor cyclopropanes. Some previous studies revealed the most importantly synthetic value of donor–acceptor cyclopropanes has been extensively demonstrated in the preparation of highly substituted carbocyclic products via formal [3 + 2] cycloaddition reactions.18 However, the main research efforts have been devoted to use the skeleton of cyclopropane for the construction of new cyclic skeletons via the ring-opening reactions of activated donor–acceptor cyclopropanes. To the best of our knowledge, no example using [3 + 2] cycloaddition reactions of 1-cyanocyclopropane 1-ester and β-nitrostyrene as starting materials to construct the five-membered cyclic cores were reported, which two carbons came from the skeleton of cyclopropane and other carbon was from its side chain. In this context, the [3 + 2] cycloaddition reactions of 1-cyanocyclopropane 1-esters and β-nitrostyrene could provide an easy access to functionalized fulvene frameworks under mildly basic conditions.
Considering their inherent high ring strain, the donor–acceptor (DA) cyclopropanes were easily promoted by basic agents to form a 2-cyano-4-oxobut-2-enoate anion, which could attack an electron-defect double or triple bond as a nucleophilic agent.19 Our initial experiments focused on the identification of an appropriate basic agent. An inorganic base screening using 1-cyclopropane1-ester 1a and β-nitrostyrene 2a as the model substrate and toluene as the solvent at 110 °C was carried out (Table 1). As a result, treatment with weak bases Na2CO3, K2CO3, Cs2CO3 or a strong base NaOH led to no [3 + 2] cycloaddition reaction (Table 1, entries 1–4). However, while organic base piperidine or triethylamine was used as a promoter, we were pleased to find out that in the presence of piperidine or triethylamine the formation of the desired product took place (Table 1, entries 5–6). Among them, 0.5 equivalent triethylamine provided the better result, affording two completely separable products as a pair of syn–anti isomers, 3a (upper in TLC) and 3a′ (lower in TLC) in 8% and 15% yields, respectively (entry 6). All these products were well characterized from spectral analysis.
Table 1 Optimization of reaction conditions in the synthesis of 3a/3a′a

|
Entry |
Base (eq.) |
Solvent |
T (°C) |
t (h) |
Yield (%) Z/E (3a/3a′) |
Isolated yield. |
1 |
Na2CO3 (1) |
PhMe |
110 |
12 |
0 |
2 |
K2CO3 (1) |
PhMe |
110 |
12 |
0 |
3 |
Cs2CO3 (1) |
PhMe |
110 |
12 |
0 |
4 |
NaOH (1) |
PhMe |
110 |
12 |
0 |
5 |
Piperidine (1) |
PhMe |
110 |
12 |
Trace |
6 |
Et3N (0.5) |
PhMe |
110 |
12 |
8/15 |
7 |
Et3N (1) |
PhMe |
110 |
12 |
17/24 |
8 |
Et3N (2) |
PhMe |
110 |
12 |
26/34 |
9 |
Et3N (3) |
PhMe |
110 |
12 |
35/41 |
10 |
Et3N (4) |
PhMe |
110 |
12 |
34/40 |
11 |
Et3N (3) |
DMF |
110 |
12 |
0 |
12 |
Et3N (3) |
Dioxane |
110 |
12 |
0 |
13 |
Et3N (3) |
PhNMe2 |
110 |
12 |
0 |
14 |
Et3N (3) |
PhMe |
80 |
12 |
19/26 |
15 |
Et3N (3) |
PhMe |
130 |
12 |
30/38 |
16 |
Et3N (3) |
PhMe |
110 |
6 |
Trace |
17 |
Et3N (3) |
PhMe |
110 |
18 |
32/39 |
Then our efforts further focused on the amount of Et3N, the yield was increased slightly when the amount of Et3N was changed from 0.5 equiv. to 2.0 equiv. (Table 1, entries 6–8). When the amount of Et3N was increased further to between 3.0 and 4.0 equiv., the reaction was complete after 12 h and the isolated yield was the best, 3a and 3a′ in ca. 35% and 41% yields, respectively (entries 9 and 10). Moreover, no product was detected when the reaction was performed in DMF, dioxane or C6H5NMe2 (entries 11–13). To our great pleasure, 3.0 equiv. Et3N promoted reaction using toluene as the solvent afforded the products 3a and 3a′ in excellent 35% and 41% yields in 12 h, respectively (entries 9). When the reaction was performed at 80 °C or 130 °C in 12 h, 3a and 3a′ were produced in lower yield (entries 14 and 15). Further reduction or addition in the reaction time also resulted in lower yield of the products.
A series of experiments revealed that the optimal results were obtained when the reaction of ethyl 2-benzoyl-3-(p-chlorophenyl)-1-cyanocyclopropane carboxylate (1a) and 1-chloro-4-(2-nitrovinyl)benzene (2a) together with 3 equiv. Et3N was carried out in toluene, the resultant mixture was stirred for 12 h at 110 °C, whereby the yields of 3a and 3a′ reached 35% and 41% (total 76%), respectively (Table 1, entry 9).
To study the scope of this reaction, we explored the use of different 1-cyanocyclopropane 1-esters, and substituted β-nitrostyrenes. The results are summarized in Table 2. The reaction tolerates different substituents on the aromatic ring of the 1-cyanocyclopropane 1-esters and substituted β-nitrostyrenes, generally, 1-cyanocyclopropane 1-ester with a range of substituents such as methyl, methoxy, chloro, and bromo at ortho-, meta- or para-positions of phenyl groups all worked well to give 2-carbamoylcyclopentadienylideneacetate derivatives. Substrates with para-position phenyl groups gave the products in higher yields than those with ortho-, or meta-position phenyl groups. The electronic properties of the substituents on the benzene ring of 1-cyanocyclopropane 1-esters had a slight effect on the reaction. The introduction of an electron-withdrawing group such as Cl or Br speeded up the reaction and increased the yield of product, thus facilitating the synthesis of diversely substituted 2-carbamoylcyclopentadienylideneacetates. However, we found that the polarity of the Z-isomer was the almost same as the E-isomer when Cl at para-positions of phenyl groups of 1-cyanocyclopropane 1-ester, the resulted Z/E-isomer mixture were not isolated easily by column chromatography (Table 2, entry 11). Additionally, while 1-cyanocyclopropane 1-esters were replaced with 1,1-dicyanopropanes as starting materials, unfortunately the desired 6-carbamoyl-6-cyanofulvenes were not yielded. All corresponding 6-carbamoylfulvene-6-carboxylates were analyzed by their 1H NMR, 13C NMR and MS. Characteristic 1H chemical shift of 6-carbamoylfulvene NH2 at δ ca. 5.40 (s) and 5.00 (s), respectively, unequivocally indicated the exclusive chemical environment of 6-carbamoyl protons. Although there were slightly differences in 1H NMR and 13C NMR of Z/E-isomer fulvenes, their configurations could not be confirmed by the 1H NMR and 13C NMR spectra of fulvene derivatives. The structure of 3h was unambiguously solved by X-ray crystallography (Fig. 1).20 X-ray crystallographic analysis determined that product 3h possess a carbamoyl and an ester contiguous substituents at C(6) of fulvene as a Z configuration of an exocyclic double bond. On the basis of spectroscopic evidence the structure of compound 3a–k was identified as (Z)1,2,4-triaryl-6-carbamoylfulvene-6-carboxylates. Furthermore, the E configuration of another isomer was also confirmed by X-ray crystallography of fulvene 3f′ and 3g′ (Fig. 2).20
Table 2 Synthesis of fulvene derivatives from 1-cyanocyclopropane 1-ester and β-nitrostyrene

|
Entry |
R1 |
R2 |
R3 |
Yielda (Z/E%) |
Isolated yield. Z/E isomer ratio determined by 1H NMR. |
1 |
H |
p-Cl |
p-Cl |
35/41 (3a/3a′) |
2 |
H |
p-Cl |
p-OCH3 |
37/42 (3b/3b′) |
3 |
p-CH3 |
p-Br |
p-OCH3 |
40/48 (3c/3c′) |
4 |
H |
p-Br |
p-OCH3 |
39/43 (3d/3d′) |
5 |
p-Cl |
m-Br |
p-OCH3 |
35/38 (3e/3e′) |
6 |
p-CH3 |
p-OCH3 |
p-OCH3 |
39/46 (3f/3f′) |
7 |
p-Br |
p-CH3 |
p-CH3 |
36/42 (3g/3g′) |
8 |
p-Cl |
o-OCH3 |
p-OCH3 |
33/39 (3h/3h′) |
9 |
p-Br |
m-Cl |
p-CH3 |
36/41 (3i/3i′) |
10 |
p-OCH3 |
p-Cl |
o-OCH3 |
37/40 (3j/3j′) |
11 |
p-Cl |
p-Cl |
p-OCH3 |
78b (3k/3k′ = 1/1) |
 |
| Fig. 1 Molecular structure of fulvene 3h. | |
 |
| Fig. 2 Molecular structure of fulvene 3f′ and 3g′. | |
A possible mechanism was proposed to rationalize the formation of 6-carbamoylfulvene-6-carboxylates (Scheme 1).
 |
| Scheme 1 Possible mechanism in the synthesis of fulvene derivatives. | |
The key steps involved the generation of a benzyl anion [A] via the carbonyl αH-elimination of 1-cyclopropane1-esters, the nucleophilic addition of [A] with a carbanion to β-nitrostyrene to give an intermediate anion [B], and the subsequent intramolecular nucleophilic addition of anion [B] to carbonyl group forming the cyclopentanol intermediate [C]. Then, in the presence of triethylamine hydrogen 1,5-shift afforded a conjugated enimine intermediate [D]. The cyclopentanol intermediate [D] was transformed to the bicyclic cyclopentane[b]furan intermediate [E] via an intramolecular nucleophilic addition again. Next the cyclopentadiene intermediate [F] was yielded through the denitration of intermediate [E] and furan-ring opening. The 6-carbamoylfulvene-6-carboxylates were finally obtained through the dehydrogenation of the cyclopentadiene intermediate [F] driven by the formation of a conjugated system.
Conclusions
In conclusion, we have developed a straightforward and efficient triethylamine-promoted annulation of 1-cyanocyclopropane 1-esters with β-nitrostyrenes for the synthesis of multi-substituted 6-carbamoylfulvene-6-carboxylates as completely separable syn–anti isomers, in moderate to good total yields (72–88%) via the reaction of readily available and activated cyclopropanes. This reaction involved the sequential [3 + 2] cyclization reaction of 2-aroyl-3-aryl-1-cyanocyclopropanecarboxylates with β-nitrostyrenes to give the corresponding nitrocyclopentanol, the formation of bicyclic cyclopentane[b]furans, removal of nitro group and dehydrogenation. The development of this strategy offered a complementary approach to highly substituted fulvene compounds with advantages that included a variety of cheap and readily available reactants and a wide range of substrates with dense or flexible substitution patterns.
Acknowledgements
Financial support of this research by the National Natural Science Foundation of China (NNSFC 21173181) is gratefully acknowledged by authors. A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.
Notes and references
-
(a) M. Potowski, J. O. Bauer, C. Strohmann, A. P. Antonchick and H. Waldmann, Angew. Chem., Int. Ed., 2012, 51, 9512 CrossRef CAS PubMed;
(b) Z. L. He, H. L. Teng and C. J. Wang, Angew. Chem., Int. Ed., 2013, 52, 2934 CrossRef CAS PubMed;
(c) D. E. Herbert, J. B. Gilroy, A. Staubitz, M. F. Haddow, J. N. Harvey and I. Manners, J. Am. Chem. Soc., 2010, 132, 1988 CrossRef CAS PubMed;
(d) B. C. Hong, Y. J. Shr, J. L. Wu, A. K. Gupta and K. J. Lin, Org. Lett., 2002, 4, 2249 CrossRef CAS PubMed;
(e) B. C. Hong, J. L. Wu, A. K. Gupta, M. S. Hallur and J. H. Liao, Org. Lett., 2004, 6, 3453 CrossRef CAS PubMed;
(f) B. C. Hong, F. L. Chen, S. H. Chen, J. H. Liao and G. H. Lee, Org. Lett., 2005, 7, 557 CrossRef CAS PubMed;
(g) B. C. Hong, A. K. Gupta, M. F. Wu, J. H. Liao and G. H. Lee, Org. Lett., 2003, 5, 1689 CrossRef CAS PubMed;
(h) E. Aqad, P. Leriche, G. Mabon, A. Gorgues and V. Khodorkovsky, Org. Lett., 2001, 3, 2329 CrossRef CAS PubMed;
(i) T. L. Andrew, J. R. Cox and T. M. Swager, Org. Lett., 2010, 12, 5302 CrossRef CAS PubMed;
(j) K. Kondo, H. Goda, K. Takemoto, H. Aso, T. Sasaki, K. Kawakami, H. Yoshida and J. Yoshida, J. Mater. Chem., 1992, 2, 1097 RSC;
(k) A. J. Peloquin, R. L. Stone, S. E. Avila, E. R. Rudico, C. B. Horn, K. A. Gardner, D. W. Ball, J. E. B. Johnson, S. T. Iacono and G. J. Balaich, J. Org. Chem., 2012, 77, 6371 CrossRef CAS PubMed;
(l) Y. Dong, Y. Geng, J. Ma and R. Huang, Organometallics, 2006, 25, 447 CrossRef CAS;
(m) A. D. Finke, O. Dumele, M. Zalibera, D. Confortin, P. Cias, G. Jayamurugan, J. P. Gisselbrecht, C. Boudon, W. B. Schweizer, G. Gescheidt and F. Diederich, J. Am. Chem. Soc., 2012, 134, 18139 CrossRef CAS PubMed;
(n) E. Shurdha, B. K. Repasy, H. A. Miller, K. Dees, S. T. Iacono, D. W. Ball and G. J. Balaich, RSC Adv., 2014, 4, 41989 RSC.
-
(a) S. Omura, H. Tomoda and H. Nishida, J. Antibiot., 1994, 4, 148 Search PubMed;
(b) F. Kuno, K. Otoguro, K. Shiomi, Y. Iwai and S. Omura, J. Antibiot., 1996, 49, 742 CrossRef CAS;
(c) V. Nair, C. N. Jayan, K. V. Radhakrishnan, G. Anilkumar and N. P. Rath, Tetrahedron, 2001, 57, 5807 CrossRef CAS;
(d) K. Strohfeldt and M. Tacke, Chem. Soc. Rev., 2008, 37, 1174 RSC;
(e) M. Tanasova and S. J. Sturla, Chem. Rev., 2012, 112, 3578 CrossRef CAS PubMed;
(f) T. D. Lash, D. A. Colby, A. S. Idate and R. N. Davis, J. Am. Chem. Soc., 2007, 129, 13800 CrossRef CAS PubMed;
(g) B. Devendar, C. P. Wu, C. Y. Chen, H. C. Chen, C. H. Chang, C. K. Ku, C. Y. Tsai and C. Y. Ku, Tetrahedron, 2013, 69, 4953 CrossRef CAS PubMed;
(h) D. Trac, B. Liu, A. C. Pao, S. V. Thomas, M. Park, C. A. Downs, H. P. Ma and M. N. Helms, Am. J. Physiol.: Renal, Fluid Electrolyte Physiol., 2013, 305, 995 CrossRef PubMed;
(i) J. L. Arbiser, Fulvene and fulvalene analogs and their use in treating cancers, US pat. 20080275016A1, 2008;
(j) D. S. Siegel, G. Piizzi, G. Piersanti and M. Movassaghi, J. Org. Chem., 2009, 74, 9292 CrossRef CAS PubMed.
-
(a) R. H. Mitchell, R. Zhang, D. J. Berg, B. Twamley and R. V. Williams, J. Am. Chem. Soc., 2009, 131, 189 CrossRef CAS PubMed;
(b) I. Garkusha, J. Fulara, A. Nagy and J. P. Maier, J. Am. Chem. Soc., 2010, 132, 14979 CrossRef CAS PubMed;
(c) C. Dahlstrand, K. Yamazaki, K. Kilsa and H. Ottosson, J. Org. Chem., 2010, 75, 8060 CrossRef CAS PubMed.
-
(a) B. C. Hong and J. H. Hong, Synth. Commun., 1997, 27, 3385 CrossRef CAS;
(b) G. A. Olah, G. K. Surya Prakash and G. Liang, J. Org. Chem., 1977, 42, 661 CrossRef CAS.
- N. Coskun and I. Erden, Tetrahedron, 2011, 67, 8607 CrossRef CAS PubMed.
-
(a) E. S. Johnson, G. J. Balaich, P. E. Fanwick and I. P. Rothwell, J. Am. Chem. Soc., 1997, 119, 11086 CrossRef CAS;
(b) U. Radhakrishnan, V. Gevorgyan and Y. Yamamoto, Tetrahedron Lett., 2000, 41, 1971 CrossRef CAS.
-
(a) G. C. M. Lee, B. Tobias, J. M. Holmes, D. A. Harcourt and M. E. Garst, J. Am. Chem. Soc., 1990, 112, 9330 CrossRef CAS;
(b) M. Kotora, H. Matsumura, G. Gao and T. Takahashi, Org. Lett., 2001, 3, 3467 CrossRef CAS PubMed;
(c) M. Uemura, Y. Takayama and F. Sato, Org. Lett., 2004, 6, 5001 CrossRef CAS PubMed.
-
(a) Y. Chen and Y. Liu, J. Org. Chem., 2011, 76, 5274 CrossRef CAS PubMed;
(b) S. Ye and J. Wu, Org. Lett., 2011, 13, 5980 CrossRef CAS PubMed;
(c) S. Ye, H. Ren and J. Wu, J. Comb. Chem., 2010, 12, 670 CrossRef CAS PubMed;
(d) C. S. Bryan and M. Lautens, Org. Lett., 2010, 12, 2754 CrossRef CAS PubMed.
- E. S. Johnson, G. J. Balaich, P. E. Fanwick and I. P. Rothwell, J. Am. Chem. Soc., 1997, 119, 11086 CrossRef CAS.
- P. Cordier, C. Aubert, M. Malacria, E. Lacote and V. Gandon, Angew. Chem., Int. Ed., 2009, 48, 8757 CrossRef CAS PubMed.
- Y. Chen and Y. Liu, J. Org. Chem., 2011, 76, 5274 CrossRef CAS PubMed.
-
(a) J. W. Xie, M. L. Xu, R. Z. Zhang, J. Y. Pan and W. D. Zhu, Adv. Synth. Catal., 2014, 356, 395 CrossRef CAS;
(b) B. Konig, W. Pitsch, M. Klein, R. Vasold, M. Prall and P. R. Schreiner, J. Org. Chem., 2001, 66, 1742 CrossRef CAS PubMed.
- R. Koch, R. J. Blanch and C. Wentrup, J. Org. Chem., 2014, 79, 6978 CrossRef CAS PubMed.
- X. Liu, X. Xu, L. Pan, Q. Zhang and Q. Liu, Org. Biomol. Chem., 2013, 11, 6703 CAS.
- Y. Zhu, M. Zhang, H. Yuan and Y. Gong, Org. Biomol. Chem., 2014, 12, 8828 CAS.
-
(a) M. A. Cavitt, L. H. Phun and S. France, Chem. Soc. Rev., 2014, 43, 804 RSC;
(b) T. F. Schneider, J. Kaschel and D. B. Werz, Angew. Chem., Int. Ed., 2014, 53, 5504 CrossRef CAS PubMed;
(c) H. K. Grover, M. R. Emmett and M. A. Kerr, Org. Biomol. Chem., 2015, 13, 655 RSC;
(d) D. J. N. Mack and J. T. Njardarson, ACS Catal., 2013, 3, 272 CrossRef CAS;
(e) Z. W. Wang, Synlett, 2012, 2311 CrossRef CAS PubMed;
(f) P. Tang and Y. Qin, Synthesis, 2012, 2969 CAS;
(g) S. E. Reisman, R. R. Nani and S. Levin, Synlett, 2011, 2437 CrossRef CAS PubMed;
(h) F. De Simone, T. Saget, F. Benfatti, S. Almeida and J. Waser, Chem.–Eur. J., 2011, 17, 14527 CrossRef CAS PubMed;
(i) M. Y. Melnikov, E. M. Budynina, O. A. Ivanova and I. V. Trushkov, Mendeleev Commun., 2011, 21, 293 CrossRef CAS PubMed;
(j) T. P. Lebold and M. A. Kerr, Pure Appl. Chem., 2010, 82, 1797 CrossRef CAS;
(k) C. A. Carson and M. A. Kerr, Chem. Soc. Rev., 2009, 38, 3051 RSC;
(l) F. De Simone and J. Waser, Chimia, 2009, 63, 162 CrossRef CAS;
(m) D. Agrawal and V. K. Yadav, Chem. Commun., 2008, 6471 RSC;
(n) H. Pellissier, Tetrahedron, 2008, 64, 7041 CrossRef CAS PubMed;
(o) A. Reichelt and S. F. Martin, Acc. Chem. Res., 2006, 39, 433 CrossRef CAS PubMed;
(p) M. Yu and B. L. Pagenkopf, Tetrahedron, 2005, 61, 321 CrossRef CAS PubMed;
(q) H. U. Reissig and R. Zimmer, Chem. Rev., 2003, 103, 1151 CrossRef CAS PubMed;
(r) J. Pietruszka, Chem. Rev., 2003, 103, 1051 CrossRef CAS PubMed;
(s) O. G. Kulinkovich, Chem. Rev., 2003, 103, 2597 CrossRef CAS PubMed.
- J. Liu, L. Zhou, W. Ye and C. Wang, Chem. Commun., 2014, 50, 9068 RSC.
-
(a) H. Xiong, H. Xu, S. Liao, Z. Xie and Y. Tang, J. Am. Chem. Soc., 2013, 135, 7851 CrossRef CAS PubMed;
(b) H. Xu, J. P. Qu, S. Liao, H. Xiong and Y. Tang, Angew. Chem., Int. Ed., 2013, 52, 404 Search PubMed;
(c) Y. Miyake, S. Endo, T. Moriyama, K. Sakata and Y. Nishibayashi, Angew. Chem., Int. Ed., 2013, 52, 1758 CrossRef CAS PubMed;
(d) W. Zhu, J. Fang, Y. Liu, J. Ren and Z. Wang, Angew. Chem., Int. Ed., 2013, 52, 2032 CrossRef CAS PubMed;
(e) S. Haubenreisser, P. Hensenne, S. Schroeder and M. Niggemann, Org. Lett., 2013, 15, 2262 CrossRef CAS PubMed;
(f) Y. A. Volkova, E. M. Budynina, A. E. Kaplun, O. A. Ivanova, A. O. Chagarovskiy, D. A. Skvortsov, V. B. Rybakov, I. V. Trushkov and M. Y. Melnikov, Chem.–Eur. J., 2013, 19, 6586 CrossRef CAS PubMed;
(g) E. O. Gorbacheva, A. A. Tabolin, R. A. Novikov, Y. A. Khomutova, Y. V. Nelyubina, Y. V. Tomilov and S. L. Ioffe, Org. Lett., 2013, 15, 350 CrossRef CAS PubMed;
(h) L. Wu and M. Shi, Chem.–Eur. J., 2010, 16, 1149 CrossRef CAS PubMed;
(i) T. P. Lebold, A. B. Leduc and M. A. Kerr, Org. Lett., 2009, 11, 3770 CrossRef CAS PubMed;
(j) C. Perreault, S. R. Goudreau, L. E. Zimmer and A. B. Charette, Org. Lett., 2008, 10, 689 CrossRef CAS PubMed;
(k) Y. Bai, J. Fang, J. Ren and Z. Wang, Chem.–Eur. J., 2009, 15, 8975 CrossRef CAS PubMed;
(l) A. Ivanova, E. M. Budynina, Y. K. Grishin, I. V. Trushkov and P. V. Verteletskii, Angew. Chem., Int. Ed., 2008, 47, 1107 CrossRef PubMed;
(m) M. K. Ghorai, R. Talukdar and D. P. Tiwari, Chem. Commun., 2013, 49, 8205 RSC;
(n) H. K. Grover, M. R. Emmett and M. A. Kerr, Org. Biomol. Chem., 2015, 13, 655 RSC.
-
(a) M. Graziano and S. Chiosi, J. Chem. Res., 1989, 44 CAS;
(b) L. Graziano, R. Iesce, F. Cermola and G. Cimminello, J. Chem. Res., 1992, 4 Search PubMed.
- ESI.†.
Footnote |
† Electronic supplementary information (ESI) available: Reactions conditions and spectra. CCDC 1040541, 1037660 and 1023075. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c5ra02918j |
|
This journal is © The Royal Society of Chemistry 2015 |
Click here to see how this site uses Cookies. View our privacy policy here.